Albemarle(R) Announces Custom Manufacturing Alliance with PharmaCore(R)
February 15 2010 - 9:09AM
PR Newswire (US)
BATON ROUGE, La., Feb. 15 /PRNewswire-FirstCall/ -- Albemarle
Corporation (NYSE:ALB), a leading global provider of custom
manufacturing services, announced today it will partner with
PharmaCore to provide manufacturing capabilities for customers with
projects that require high volume capacity. (Logo:
http://www.newscom.com/cgi-bin/prnh/20050801/ALBEMARLELOGO ) This
alliance allows a seamless technology transfer from PharmaCore to
Albemarle, offering PharmaCore customers long term, higher volume
capacity for their pharmaceutical projects. Albemarle's custom
manufacturing capabilities include a network of manufacturing
assets in South Haven, Mich., Tyrone, Pa. and Orangeburg, S.C.,
providing Active Pharmaceutical Ingredients (APIs) and advanced
pharmaceutical intermediate production in a broad range of scale
and chemistries. "We are happy that PharmaCore chose Albemarle's
custom manufacturing business unit, Fine Chemistry Services (FCS),
to expand their expertise as a custom synthesis provider for their
customers," said Steve LeVan, Albemarle's vice president of FCS. "I
am confident that PharmaCore's valued customers will benefit from
our premier service and production capabilities and look forward to
partnering with each of them to bring their products to market
quickly and effectively." "Our customers already benefit from
PharmaCore's med-chem services through current Good Manufacturing
Practices (cGMP) pilot plant capabilities. This new partnership
with Albemarle will complete the process," said Brian Swierenga,
PharmaCore's vice president of GMP operations. "We have formed long
business relationships with many of our customers, synthesizing
first batches for toxicology continuing through lab process
development and ultimately providing cGMP material for clinical
trials. This new Albemarle partnership offers an opportunity to
transfer that learned technology to full-scale manufacturing."
Albemarle's FCS division is a leading provider of products, custom
manufacturing and process scale-up services to a wide variety of
industries including pharmaceuticals, crop protection and other
specialty markets. The FCS division boasts rapid response time and
flexible manufacturing, including two cGMP plants in the United
States and several custom manufacturing plants in the United States
and Europe. About Albemarle Albemarle Corporation, headquartered in
Baton Rouge, Louisiana, is a leading global developer,
manufacturer, and marketer of highly-engineered specialty chemicals
for consumer electronics, petroleum refining, utilities, packaging,
construction, automotive/transportation, pharmaceuticals, crop
protection, food-safety and custom chemistry services. The Company
is committed to global sustainability and is advancing its
eco-practices and solutions in its three business segments, Polymer
Solutions, Catalysts, and Fine Chemicals. Albemarle employs over
4,100 people and serves customers in approximately 100 countries.
To learn more, visit http://www.albemarle.com/. About PharmaCore
PharmaCore®, Inc., headquartered in High Point, N.C., is an
industry leader in custom organic synthesis, using diverse
chemistries to produce pharmaceutical intermediates and API's. The
company's business offerings consist of a variety of chemistry
outsourcing functions, including: medicinal chemistry services;
chemical process and development; cGMP scale-up; and cGMP
analytical services. PharmaCore has served customers globally since
2000. Additional information is available at
http://www.pharmacore.com/. "Safe Harbor" Statement under the
Private Securities Litigation Reform Act of 1995: Statements in
this press release regarding Albemarle Corporation's business that
are not historical facts are "forward-looking statements" that
involve risks and uncertainties. For a discussion of such risks and
uncertainties, which could cause actual results to differ from
those contained in the forward-looking statements, see "Risk
Factors" in the Company's Annual Report on Form 10-K.
http://www.newscom.com/cgi-bin/prnh/20050801/ALBEMARLELOGO
http://photoarchive.ap.org/ DATASOURCE: Albemarle Corporation
CONTACT: Brandi Narez, +1-225-388-7505, , Investor Relations
Contact: Sandra Rodriguez, +1-225-388-7654, Web Site:
http://www.albemarle.com/
Copyright